Author

Barbieri Antonio

IRCCS Istituto Nazionale Tumori Fondazione Pascale SSD Sperimentazione Animale - Cited by 4,240 - Oncologia

Biography

Dr.  Barbieri Antonio  works in Department of Oncologia is a well known researcher in field of Oncologia. One of their renowned works are Dissecting the Roles of Natural Killer T cells in Autoimmune Disorders and Malignancy
Title
Cited by
Year
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
V Quagliariello, M De Laurentiis, D Rea, A Barbieri, MG Monti, A Carbone, ...Cardiovascular diabetology 20 (1), 1-20, 2021202
104
2021
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA …
P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ...European journal of heart failure 22 (8), 1378-1389, 2020202
83
2020
Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry
M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ...European journal of heart failure 22 (1), 92-102, 2020202
60
2020
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
C D’Alterio, M Buoncervello, C Ieranò, M Napolitano, L Portella, G Rea, ...Journal of Experimental & Clinical Cancer Research 38, 1-13, 2019201
60
2019
Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge
S Bimonte, M Cascella, A Barbieri, C Arra, A CuomoInfectious Agents and Cancer 15, 1-6, 2020202
40
2020
Evidences of CTLA-4 and PD-1 blocking agents-induced cardiotoxicity in cellular and preclinical models
V Quagliariello, M Passariello, D Rea, A Barbieri, M Iovine, A Bonelli, ...Journal of Personalized Medicine 10 (4), 179, 2020202
36
2020
Can beta-2-adrenergic pathway be a new target to combat Sars-Cov-2 hyperinflammatory syndrome?—lessons learned from cancer
A Barbieri, N Robinson, G Palma, N Maurea, V Desiderio, G BottiFrontiers in immunology 11, 2615, 2020202
35
2020
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure Long …
A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ...European Journal of Heart Failure 24 (2), 335-350, 2022202
31
2022
PI3Kδ inhibition as a potential therapeutic target in COVID-19
G Palma, T Pasqua, G Silvestri, C Rocca, P Gualtieri, A Barbieri, ...Frontiers in immunology 11, 2094, 2020202
24
2020
β2-AR blockade potentiates MEK1/2 inhibitor effect on HNSCC by regulating the Nrf2-mediated defense mechanism
L Mele, V Del Vecchio, F Marampon, T Regad, S Wagner, L Mosca, ...Cell Death & Disease 11 (10), 850, 2020202
13
2020
HMGA1-pseudogene7 transgenic mice develop B cell lymphomas
M De Martino, D De Biase, F Forzati, SC Credendino, G Palma, A Barbieri, ...Scientific Reports (1), 7057, 2020202
10
2020
Novel peptide-based PET probe for non-invasive imaging of CXC chemokine receptor type 4 (CXCR4) in tumors
AM Trotta, M Aurilio, C D’Alterio, C Ierano, D Di Martino, A Barbieri, ...Journal of Medicinal Chemistry 64 (6), 3449-3461, 2021202
8
2021
Potential mechanisms by which glucocorticoids induce breast carcinogenesis through Nrf2 inhibition
A Giudice, SM Aliberti, A Barbieri, P Pentangelo, I Bisogno, G D’Arena, ...Frontiers in Bioscience-Landmark 2 (), 223, 2022202
7
2022
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways
V Quagliariello, M Passariello, A Di Mauro, C Cipullo, A Paccone, ...Frontiers in Cardiovascular Medicine 9, 9309, 2022202
7
2022
SGLT2 inhibitor dapagliflozin against anthracycline and trastuzumab-induced cardiotoxicity: the role of MYD88, NLRP3, Leukotrienes/Interleukin 6 axis and mTORC1/Fox01/3a …
SGLT2 inhibitor dapagliflozin against anthracycline and trastuzumab-induced cardiotoxicity: the role of MYD88, NLRP3, Leukotrienes/Interleukin axis and mTORC1/Fox01/3a …V Quagliariello, M De Laurentiis, D Rea, A Barbieri, MG Monti, G Botti, ...European Heart Journal 41 (Supplement_2), ehaa94. 3253, 2020202
6
2020
Aneurismal subarachnoid hemorrhage during the COVID-19 outbreak in a Hub and Spoke system: observational multicenter cohort study in Lombardy, Italy
A Fiorindi, M Vezzoli, F Doglietto, L Zanin, G Saraceno, E Agosti, ...Acta Neurochirurgica, 1-10, 2021202
4
2021
MHC-optimized peptide scaffold for improved antigen presentation and anti-tumor response
M Tagliamonte, A Mauriello, B Cavalluzzo, C Ragone, C Manolio, ...Frontiers in Immunology 12, 769799, 2021202
3
2021
Non-covalent strategies to functionalize polymeric nanoparticles with NGR peptides for targeting breast cancer
C Conte, G Longobardi, A Barbieri, G Palma, A Luciano, G Dal Poggetto, ...International Journal of Pharmaceutics 633, 2268, 2023202
1
2023
54 Sacubitril–valsartan (LCZ 696) improves longitudinal strain and ejection fraction in preclinical models treated with doxorubicin through NLRP3, MyD88, and pro-fibrotic …
V Quagliariello, S Buccolo, M Iovine, F Maurea, D Rea, A Barbieri, ...European Heart Journal Supplements 23 (Supplement_G), suab30. 008, 20220
1
2021
Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
A Mauriello, B Cavalluzzo, C Manolio, C Ragone, A Luciano, A Barbieri, ...Journal of Translational Medicine 9 (), -2, 20220
1
2021

Referred From: https://scholar.google.co.in/citations?user=mJCrSJAAAAAJ&hl=en

Cited by
Citations 4240
h-index 39
i10-index 83
Recommended Journals
Open Access Journals